143 related articles for article (PubMed ID: 19010181)
1. Adverse effects of mammalian target of rapamycin inhibitors during the postoperative period after cardiac transplantation.
Bouzas-Mosquera A; Crespo-Leiro MG; Paniagua MJ; Naya C; Grille Z; Marzoa R; Barge-Caballero E; Estévez-Cid F; Alvarez-García N; Cuenca JJ; Castro-Beiras A
Transplant Proc; 2008 Nov; 40(9):3027-30. PubMed ID: 19010181
[TBL] [Abstract][Full Text] [Related]
2. Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients.
Sathya CJ; Sheshgiri R; Prodger J; Tumiati L; Delgado D; Ross HJ; Rao V
Transpl Int; 2010 Jun; 23(6):641-8. PubMed ID: 20102553
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibitors and their secondary effects in cardiac transplant recipients: a descriptive study.
Moro J; Almenar L; Martínez-Dolz L; Izquierdo M; Rueda J; Arnau MA; Agüero J; Sánchez-Lázaro I; Ortiz V; Salvador A
Transplant Proc; 2007 Sep; 39(7):2365-7. PubMed ID: 17889191
[TBL] [Abstract][Full Text] [Related]
4. Incidence and importance of de novo diabetes mellitus after heart transplantation.
Mogollón Jiménez MV; Sobrino Márquez JM; Arizón Muñoz JM; Sánchez Brotons JA; Guisado Rasco A; Hernández Jiménez MM; Romero Rodríguez N; Borrego Domínguez JM; Ordoñez Fernández A; Lage Gallé E; Martínez Martínez A
Transplant Proc; 2008 Nov; 40(9):3053-5. PubMed ID: 19010191
[TBL] [Abstract][Full Text] [Related]
5. Association between parapneumonic effusion and pericardial effusion in a pediatric cohort.
Roberts JE; Bezack BJ; Winger DI; Pollack S; Shah RA; Cataletto M; Katz DS; Montoya-Iraheta C; Schroeder SA; Quintos-Alagheband ML
Pediatrics; 2008 Dec; 122(6):e1231-5. PubMed ID: 18984649
[TBL] [Abstract][Full Text] [Related]
6. Pericardial effusion coincident with sirolimus therapy: a review of Wyeth's safety database.
Steele GH; Adamkovic AB; Demopoulos LA; Rothrock LC; Caulfield ME; Blum MD; Schubert CM; Hembekides DD; Singh AB
Transplantation; 2008 Feb; 85(4):645-7. PubMed ID: 18347546
[TBL] [Abstract][Full Text] [Related]
7. Effect of posterior pericardial drainage on the incidence of pericardial effusion after ascending aortic surgery.
Eryilmaz S; Emiroglu O; Eyileten Z; Akar R; Yazicioglu L; Tasoz R; Kaya B; Uysalel A; Ucanok K; Corapcioglu T; Ozyurda U
J Thorac Cardiovasc Surg; 2006 Jul; 132(1):27-31. PubMed ID: 16798298
[TBL] [Abstract][Full Text] [Related]
8. Colchicine prevents early postoperative pericardial and pleural effusions.
Imazio M; Brucato A; Rovere ME; Gandino A; Cemin R; Ferrua S; Maestroni S; Zingarelli E; Barosi A; Simon C; Sansone F; Patrini D; Vitali E; Belli R; Ferrazzi P; Trinchero R; Spodick DH; Adler Y
Am Heart J; 2011 Sep; 162(3):527-32.e1. PubMed ID: 21884871
[TBL] [Abstract][Full Text] [Related]
9. Progression of renal dysfunction in cardiac transplantation after the introduction of everolimus in the immunosuppressive regime.
Moro López JA; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Agüero J; Buendía F; Ortiz V; Salvador A
Transplantation; 2009 Feb; 87(4):538-41. PubMed ID: 19307790
[TBL] [Abstract][Full Text] [Related]
10. Surgical wound-healing complications in heart transplant recipients treated with rapamycin.
Zakliczynski M; Nozynski J; Kocher A; Lizak MK; Zakliczynska H; Przybylski R; Wojarski J; Zembala M
Wound Repair Regen; 2007; 15(3):316-21. PubMed ID: 17537118
[TBL] [Abstract][Full Text] [Related]
11. [No consequences of prolonged drainage following open heart surgery on the incidence of postoperative pericardial effusion].
Smulders YM; Wiepking ME; Moulijn AC; Koolen JJ; Visser CA
Ned Tijdschr Geneeskd; 1991 May; 135(18):798-802. PubMed ID: 2052097
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of mediastinitis after cardiac transplantation.
Chou NK; Wang JL; Chi NH; Wu IH; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Su HY; Chang SC; Chu SH; Wang SS
Transplant Proc; 2008 Oct; 40(8):2629-30. PubMed ID: 18929822
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
Celik S; Doesch A; Erbel C; Blessing E; Ammon K; Koch A; Katus HA; Dengler TJ
Transplantation; 2008 Jul; 86(2):245-50. PubMed ID: 18645486
[TBL] [Abstract][Full Text] [Related]
14. [Posttransplant complications in cardiac transplant recipients at National Cardiovascular Center].
Kato T; Nakatani T; Kitamura S
Kyobu Geka; 2007 Oct; 60(11):963-8. PubMed ID: 17926898
[TBL] [Abstract][Full Text] [Related]
15. A comparison of atrial arrhythmias after heart or double-lung transplantation at a single center: insights into the mechanism of post-operative atrial fibrillation.
Dizon JM; Chen K; Bacchetta M; Argenziano M; Mancini D; Biviano A; Sonett J; Garan H
J Am Coll Cardiol; 2009 Nov; 54(22):2043-8. PubMed ID: 19926011
[TBL] [Abstract][Full Text] [Related]
16. The role of mTOR inhibitors in the management of posttransplant malignancy.
Monaco AP
Transplantation; 2009 Jan; 87(2):157-63. PubMed ID: 19155967
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and risk factors for neurologic complications after heart transplantation.
Pérez-Miralles F; Sánchez-Manso JC; Almenar-Bonet L; Sevilla-Mantecón T; Martínez-Dolz L; Vílchez-Padilla JJ
Transplant Proc; 2005 Nov; 37(9):4067-70. PubMed ID: 16386628
[TBL] [Abstract][Full Text] [Related]
18. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
[TBL] [Abstract][Full Text] [Related]
19. Effects of everolimus monotherapy on hematological parameters and iron homeostasis in de novo liver transplant recipients: preliminary results.
Masetti M; Rompianesi G; Montalti R; Romano A; Spaggiari M; Ballarin R; Guerrini GP; Gerunda GE
Transplant Proc; 2008; 40(6):1947-9. PubMed ID: 18675097
[TBL] [Abstract][Full Text] [Related]
20. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
